BIGHIANI, FEDERICO
 Distribuzione geografica
Continente #
AS - Asia 138
EU - Europa 136
NA - Nord America 133
SA - Sud America 25
Totale 432
Nazione #
US - Stati Uniti d'America 127
SG - Singapore 52
CN - Cina 37
RU - Federazione Russa 33
IT - Italia 25
DE - Germania 23
HK - Hong Kong 23
BR - Brasile 21
GB - Regno Unito 14
VN - Vietnam 13
FI - Finlandia 12
AT - Austria 6
IE - Irlanda 6
FR - Francia 4
IN - India 4
NL - Olanda 4
BD - Bangladesh 3
CA - Canada 3
MX - Messico 3
CO - Colombia 2
CZ - Repubblica Ceca 2
PL - Polonia 2
AL - Albania 1
AR - Argentina 1
BH - Bahrain 1
EC - Ecuador 1
GR - Grecia 1
IQ - Iraq 1
JP - Giappone 1
LV - Lettonia 1
OM - Oman 1
PT - Portogallo 1
SA - Arabia Saudita 1
SE - Svezia 1
TH - Thailandia 1
Totale 432
Città #
Hong Kong 23
Dallas 22
Singapore 22
Beijing 18
Ashburn 16
Munich 15
Los Angeles 14
Turku 9
Milan 8
Rome 8
Dublin 6
Moscow 6
Brooklyn 5
Ho Chi Minh City 5
Boston 4
Falkenstein 4
Redondo Beach 4
Boardman 3
Cremona 3
Helsinki 3
New York 3
Orem 3
Poplar 3
Vienna 3
Amsterdam 2
Buffalo 2
Cormano 2
Cuiabá 2
Denver 2
Dongguan 2
Düsseldorf 2
Manchester 2
Mexico City 2
Montreal 2
Olomouc 2
Portsmouth 2
Santa Clara 2
Shanghai 2
Warsaw 2
Athens 1
Atlanta 1
Bangkok 1
Barranquilla 1
Belo Horizonte 1
Bologna 1
Brasília 1
Campinas 1
Canoas 1
Caraguatatuba 1
Caruaru 1
Chandigarh 1
Changsha 1
Charleston 1
Chennai 1
Chicago 1
City of London 1
Dhaka 1
Duque de Caxias 1
Erbil 1
Fountain Valley 1
Germantown 1
Goiânia 1
Grand Rapids 1
Guayaquil 1
Ha Long 1
Hanoi 1
Hefei 1
Hyderabad 1
Hải Dương 1
Iaciara 1
Itapecerica 1
Jequié 1
Lauro de Freitas 1
Lauterbourg 1
London 1
Manama 1
Manhuaçu 1
Medina 1
Miami 1
Mogi Guaçu 1
Montes Claros 1
Mumbai 1
Muscat 1
Nam Định 1
Necochea 1
Ninh Bình 1
Pasto 1
Ramenskoye 1
Riga 1
Rio Brilhante 1
Rock Hill 1
Saronno 1
Serra 1
Shenzhen 1
Stockholm 1
São José do Rio Preto 1
São Paulo 1
Thái Bình 1
Tirana 1
Tokyo 1
Totale 301
Nome #
Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial 79
Differences in Trunk Acceleration-Derived Gait Indexes in Stroke Subjects with and without Stroke-Induced Immunosuppression 61
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting 57
Expression of miR-155 in monocytes of people with migraine: association with phenotype, disease severity and inflammatory profile 47
Multiscale Entropy Algorithms to Analyze Complexity and Variability of Trunk Accelerations Time Series in Subjects with Parkinson’s Disease 44
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting 42
High-frequency episodic migraine: Time for its recognition as a migraine subtype? 37
Expression of miR-155 in monocytes of people with migraine: association with phenotype, disease severity and inflammatory profile 33
Oculo-vestibular signs in experimentally induced migraine attacks: an exploratory analysis 32
null 11
Clinical and instrumental gait phenotyping in people with GLUT-1 deficiency syndrome 8
Totale 451
Categoria #
all - tutte 1.997
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.997


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202310 0 0 0 0 1 0 0 1 7 1 0 0
2023/202414 2 1 1 0 2 0 0 0 0 1 1 6
2024/2025211 3 2 5 2 6 39 26 8 44 11 30 35
2025/2026216 44 27 29 43 70 3 0 0 0 0 0 0
Totale 451